Abstract:Physical-based gene delivery via biolistic methods (such as the Helios gene gun) involve precipitation of nucleic acids onto microparticles and direct transfection through cell membranes of exposed tissue ( e.g. skin) by high velocity acceleration. The glycosaminoglycan (GAG)-binding enhanced transduction (GET) system exploits novel fusion peptides consisting of cell-binding, nucleic acid condensing, and cell-penetrating domains, which enable enhanced transfection across multiple cell types. In this study, we combined chemical (GET) and physical (gene gun) DNA delivery systems, and hypothesized the combination would generate enhanced distribution and effective uptake in cells not initially transfected by biolistic penetration. Physicochemical characterization, optimization of bullet contents and transfection experiments in vitro in cell monolayers and engineered tissue demonstrated these formulations transfected efficiently, including DC2.4 dendritic cells. We incorporated these formulations into a biolistic format for gene gun by forming fireable dry bullets obtained via lyophilization (freeze drying). This system is simple and with enhanced scalability compared to conventional methods to generate bullets. Flushed GET bullet contents retained their ability to mediate transfection (17-fold greater and 13-fold greater reporter gene expression than standard spermidine bullets in the absence and presence of serum, respectively). Fired GET bullets in vitro (in cells and collagen gels) and in vivo (mice) showed increased reporter gene transfection compared to untreated controls, whilst maintaining cell viability in vitro and having no obvious toxicity in vivo . Lastly, a SARS-CoV-2 plasmid DNA vaccine with spike (S) protein-receptor binding domain (S-RBD) was delivered by gene gun using GET bullets. Specific T cell and antibody responses comparable to the conventional system were generated. The non-physical and physical combination of GET‐gold-DNA carriers using gene gun shows potential as an alternative DNA delivery method that is scalable for mass deployable vaccination and intradermal gene delivery.

Technique of Particle Acceleration Applied to Deliver DNA Vaccine into Skin in Vivo

Particle Acceleration for Delivery Deoxyribonucleic Acid Vaccine into Skin in Vivo

Designable Immune Therapeutical Vaccine System Based on DNA Supramolecular Hydrogels.

A Promising Needle-Free Pyro-Drive Jet Injector for Augmentation of Immunity by Intradermal Injection as a Physical Adjuvant

Microneedles Improve the Immunogenicity of DNA Vaccines.

Efficient Delivery of Nucleic Acid Molecules into Skin by Combined Use of Microneedle Roller and Flexible Interdigitated Electroporation Array.

Combined biolistic and cell penetrating peptide delivery for the development of scalable intradermal DNA vaccines

Transdermal Delivery of Nucleic Acid Mediated by Punching and Electroporation

Efficient Delivery of DNA Using Lipid Nanoparticles

Separable Microneedle Patch to Protect and Deliver DNA Nanovaccines Against COVID-19

Delivery systems for intradermal vaccination

Nanoparticles for DNA Vaccine Delivery

Iontophoresis‐Driven Microneedle Arrays Delivering Transgenic Outer Membrane Vesicles in Program That Stimulates Transcutaneous Vaccination for Cancer Immunotherapy

Novel suction-based in vivo cutaneous DNA transfection platform

Local gene expression and immune responses of vaginal DNA vaccination using a needle-free injector

Needle-free injection into skin and soft matter with highly focused microjets

Immunogenic Comparison of Nucleic Acid-Based Vaccines Administered by Pyro-Drive Jet Injector

Successive Site Translocating Inoculation Potentiates DNA/recombinant Vaccinia Vaccination

A nasal spray vaccination device based on Laval nozzle and its experimental test

A New Potent Route of DNA Vaccine Inoculation: DNA-Liposome Complexes on Bare Skin Induce Antigen-Special Antibody Responses

Non-invasive Oil-Based Method to Increase Topical Delivery of Nucleic Acids to Skin